Share on StockTwits

Castlight Health (NASDAQ:CSLT)‘s stock had its “outperform” rating reiterated by investment analysts at Raymond James in a note issued to investors on Wednesday. They currently have a $19.00 price objective on the stock, up from their previous price objective of $15.00. Raymond James’ price target suggests a potential upside of 34.66% from the stock’s previous close.

Shares of Castlight Health (NASDAQ:CSLT) traded down 4.73% during mid-day trading on Wednesday, hitting $14.11. The stock had a trading volume of 642,789 shares. Castlight Health has a one year low of $10.05 and a one year high of $41.95. The stock’s 50-day moving average is $15.21 and its 200-day moving average is $17.53. The company’s market cap is $1.263 billion.

Castlight Health (NASDAQ:CSLT) last released its earnings data on Tuesday, July 29th. The company reported ($0.21) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.22) by $0.01. The company had revenue of $10.50 million for the quarter, compared to the consensus estimate of $9.50 million. The company’s quarterly revenue was up 351.9% on a year-over-year basis. Analysts expect that Castlight Health will post $-1.02 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Stifel Nicolaus set a $17.00 price target on shares of Castlight Health in a research note on Thursday, May 8th. They now have a “buy” rating on the stock. Analysts at Canaccord Genuity cut their price target on shares of Castlight Health from $25.00 to $18.00 in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Castlight Health has an average rating of “Hold” and a consensus target price of $19.00.

Castlight Health, Inc is a provider of cloud-based software, that enables enterprises to gain control over their rapidly escalating health care costs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.